Sales of Anticoagulant are Expected to Reach US$ 65 Billion by the end of 2032, Says Fact.MR

By the end of 2021, it's anticipated that anticoagulant sales would total $30 billion USD. According to the report, demand will keep growing and increase by more than two times to reach a value of US$ 65 billion by the conclusion of the evaluation period of 2021-2031.

Players are using online sales channels more frequently to increase their reach while putting out less of a financial investment. The patient pool for the anticoagulants market is anticipated to grow due to the increased incidence of heart attacks, which is caused by patients' bad lifestyle choices, throughout the course of the forecast period.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4335?AS 

"Manufacturers are capitalizing on online sales channels to fulfil growing demand for effective anticoagulant medications in underdeveloped countries, encouraging producers to seek undiscovered areas with less investment in distribution infrastructure", says the Fact.MR Analyst.

Key Takeaways:

Until 2031, the global market for anticoagulants is expected to grow by more than double.
In 2020, oral anticoagulants accounted for roughly 54% of revenue by route of administration.
Factor-X inhibitors (NOAC/DOAC) anticoagulants accounted for over 50% of global demand in 2019
Hospitals continue to be the key anticoagulant disbursers, accounting for 49.5% of total sales. The United States is an attractive market, with a CAGR of 7.5 percent until 2031.

In East Asia, Japan is expected to account for more than two out of every five anticoagulant sales.
Through 2031, China is predicted to expand at the fastest rate, with an annual growth rate of 8%.
Growth Drivers:

Development of online pharmacies to drive the sales of anticoagulant medications.
Financial assistance given by central governments to renovate healthcare facilities and improve service quality to propel the market demand.
Prominent players are utilizing R&D operations to increase the number of pipeline medicines thus driving the anticoagulants market growth.

Competitive Landscape

With multiple top players, the anticoagulants market is competitive and fragmented. Anticoagulant market players are stepping forward to share the financial burden of individuals through patient-assistance programs as a tactic to boost anticoagulant exposure.

For instance, The Bristol-Myers Squibb Foundation gives financial support to patients so that they can obtain drugs. However, the program only helps US citizens who are not insured by a privately or publicly traded company.

The PRADAXA savings card, which is provided by Boehringer Ingelheim, allows patients to purchase drugs at a discounted cost. Throughout the forecast period, an increase in the number of producers using financial techniques is expected to raise the drug consumption.

Top Manufacturers of Anticoagulants are:

Bayer AG
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Daiichi Sankyo Company Ltd.
Sanofi SA
Johnson & Johnson

More Valuable Insights on Anticoagulants Market

Fact.MR provides an unbiased analysis of the anticoagulants market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global anticoagulant market with a detailed segmentation on the basis of:

By Drug Class
• Factor X Inhibitor (NOAC/DOAC) Anticoagulants
• Heparin Anticoagulants
• Direct Thrombin Inhibitor Anticoagulants
• Vitamin K Antagonist Anticoagulants

• By Indication
• Deep Vein Thrombosis
• Pulmonary Embolism
• Atrial Fibrillation & Heart Attack
• Other Indications

• By Route of Administration
• Oral Anticoagulants
• Injectable Anticoagulants

• By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

• By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Covered in the Anticoagulant Market Report 

The report offers insight into anticoagulants market demand outlook for 2021-2031
The market study also highlights projected sales growth for anticoagulants market between 2021 and 2031
Anticoagulants market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry 
Anticoagulants market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others 

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4335?AS 

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR;

Fact.MR research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.

This release was published on openPR.